4,746.00
+18.00
+(0.38%)
At close: March 3 at 5:32:25 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 28 | 28 | 36 | 34 |
Avg. Estimate | 4.58B | 6.37B | 25.3B | 27.49B |
Low Estimate | 4.48B | 6.15B | 24.87B | 26.01B |
High Estimate | 4.66B | 6.61B | 25.91B | 28.58B |
Year Ago Sales | 4.42B | 5.86B | 23.74B | 25.3B |
Sales Growth (year/est) | 3.75% | 8.81% | 6.58% | 8.66% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
BOOK.VI | -- | -- | -- | -- |
S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 2/24/2025 |
Maintains | UBS: Buy to Buy | 2/21/2025 |
Maintains | Citigroup: Buy to Buy | 2/21/2025 |
Maintains | BMO Capital: Outperform to Outperform | 2/21/2025 |
Maintains | RBC Capital: Outperform to Outperform | 2/21/2025 |
Maintains | Cantor Fitzgerald: Neutral to Neutral | 2/21/2025 |